1. Introduction {#sec1}
===============

The major interest of regional anesthesia (central or peripheral nerve block) in clinical practice remains to replace or supplement general anesthesia for certain types of surgery and to provide efficient pain relief in the postoperative period. Being able to continue the block in the postoperative period allows a more effective pain control and a reduction of opioid-related side effects \[[@B1], [@B2]\]. While the improved patient comfort is undoubted, an overall improvement in long-term patient outcome is less evident and combining general anesthesia with a regional analgesic technique exposes the patient to the risk of both techniques. Since the concept of pain treatment as a fundamental human right has emerged, the use of invasive pain treatment is warranted already for the improvement of acute postoperative pain treatment \[[@B3]\]. Efficacy of nerve blockade on serious complications in the postoperative period (major morbidity or mortality) is hard to demonstrate because of their low incidence \[[@B4]\]. The possibility of preventing chronic postsurgical pain is becoming a major issue \[[@B3], [@B5], [@B6]\]. In the clinical research literature, there are only few reports showing a benefit of regional analgesic techniques on the incidence of chronic postoperative pain states. Two RCT demonstrated a reduction of the incidence of chronic postthoracotomy pain in patients treated with peri- and postoperative epidural analgesia as compared to patients without postoperative epidural analgesia \[[@B7], [@B8]\]. Further, a single paravertebral block reduced the incidence of postmastectomy pain one year following surgery as compared to a sham puncture \[[@B9]\]. Whereas the incidence of phantom limb pain after amputation was not influenced by epidural analgesia \[[@B10]\]. Surrogate outcomes are studied to increase the indications of regional analgesic techniques: length of hospital stay, improvement on long-term function after surgery (in orthopedics) and, newly, cancer recurrence \[[@B11]\], and reduction in surgical site infection \[[@B12]\]. Experimental research on humans and animals could help to define more clearly the working hypothesis of clinical trials and their design.

Current pain treatment should use a mechanistic-based approach. The best mechanistic knowledge in patient to-date is obtained from quantitative sensory testing (QST) where different modalities of sensation are tested. There is a gap between the sensory testing in human and the cellular and molecular vision offered in an experimental laboratory setting. The experimental setting also allows different types of blockade, using drugs with specificities on nerve fiber types, longer duration, or motor blockade, all of which cannot be tested on patients unless strong evidence has been gathered beforehand in experimental studies.

This paper is therefore intended to focus on the effect of nerve blockade on pain-related behavior and central changes that occur after peripheral tissue injury in animals (e.g., rats and mice) and build a bridge to clinical practice. We will try to point out some discoveries in bench research that would answer questions or lead to research ideas around the operating room.

2. Pathophysiology of Peripheral Discharges and Central Mechanisms of Persistent Pain {#sec2}
=====================================================================================

2.1. Peripheral Activity and Central Sensitization: A Potential Contribution to Chronic Postoperative Pain {#sec2.1}
----------------------------------------------------------------------------------------------------------

The potential benefits of regional analgesic techniques rely on the ability of local anesthetics to reduce or abolish the peripheral input electrically transmitted by the nerve. Tissue injury and/or inflammation (with potential nerve lesion) during surgery lead to a massive input of action potentials along the primary afferents. The first relay of the information in the central nervous system (CNS) is the spinal cord dorsal horn. The glutamate release at the synapses in the dorsal horn induces a depolarization in the second-order neuron. If its amplitude is large enough, it triggers an action potential that conducts the information to higher centers. Cumulative afferent inputs gradually sensitize second-order neurons, which become more reactive to subsequent inputs. This global process of signal enhancement in the CNS is called central sensitization and encompasses increased membrane excitability, synaptic efficacy, and reduced inhibition. Central sensitization and its dependency on primary afferent activity has been extensively reviewed by Latremoliere and Woolf \[[@B13]\]. It is often described in 2 temporal phases an early short lasting, transcription-independent phase caused by phosphorylation mechanisms and a late longer lasting phase dependant on transcription and synthesis of new proteins \[[@B14]\]. Central sensitization is triggered by primary afferent release of glutamate which binds on postsynaptic ionotropic (AMPA (amino-3-hydroxy-5-methyl-4-isoxazole propionate), NMDA (N-methyl-D-Aspartate) and kainate), and metabotropic (mGluR 1--8, not all expressed in spinal cord) receptors. Under normal stimulation, the NMDA receptor is blocked by a magnesium (Mg^++^) ion in a voltage-dependent manner. Following sustained activity as in the case of surgery, the Mg^++^ block is released and glutamate can open the NMDA receptor leading to greater calcium entry in the spinal cord neuron, the first step of central sensitization. This is enhanced by the neuropeptides Substance P and CGRP, also released from primary afferents. The increase in cellular calcium in the dorsal horn neuron appears to be the trigger for the next step of central sensitization implicating activation of kinases (protein kinase A (PKA), C (PKC), or calmodulin kinase II (CaMKII)). These kinases phosphorylate different channels thereby increasing their trafficking to the membrane or changing their biophysical properties globally enhancing their response. Other targets in the later phases of the sensitization phenomenon include mitogen-activating kinases (MAPKs) such as extracellular signal-regulated kinase (ERK) and transcription factors finally leading to changes in gene expression.

2.2. Characterization of Spontaneous Discharges after Nerve Injury {#sec2.2}
------------------------------------------------------------------

Spontaneous activity occurs from the neuroma (unregulated regeneration of the nerve stump after injury) after nerve section \[[@B15], [@B16]\], and there have been numerous descriptions of increased peripheral activity after nerve injury, in different neuropathic pain models ([Figure 1](#fig1){ref-type="fig"}) and at different timepoints after injury. Most agree that ectopic activity in primary afferent after nerve injury arises from multiple sites (the neuroma, along the nerve, or in the dorsal root ganglion (DRG)) \[[@B17], [@B18]\]. However, there are still controversies about which type of fibers (injured versus noninjured fibers or myelinated versus unmyelinated fibers) \[[@B17]\]. Since the early recordings following axotomy, different animal models of neuropathic pain ([Figure 1](#fig1){ref-type="fig"}) were developed, many consisting of partial nerve lesions. They lead to various configurations between intact and injured nerve fibers. In chronic constriction injuries (CCI, originally described by Bennett and Xie \[[@B19]\] and modified by Mosconi and Kruger \[[@B20]\]), mostly myelinated fibers are injured, leaving neighboring C-fibers relatively undamaged \[[@B21]\]. In the spinal nerve ligation model (SNL) model \[[@B22]\], intact roots are in contact distally with the degenerating fibers of the injured roots and in the spared nerve injury (SNI) model \[[@B23]\] intact fibers are in contact with the proximal part of the injured nerves.

Summarizing all studies on peripheral nerve activity recordings is difficult but we will take out the general ideas. Most researchers consider A-fibers as the principal contributors to peripheral ectopic firing following nerve injury \[[@B24]--[@B28]\]. Nevertheless, activity in the unmyelinated C-fibers was recorded either very early, during the first 15 minutes after a nerve lesion \[[@B29]\], or later, after a few days \[[@B30]\]. C-fiber activity was also recorded after spinal nerve ligation in the neighbored intact spinal nerve \[[@B31]\] or after stimulation of a nerve stump with nociceptive mediators \[[@B32]\]. This underlines the importance of uninjured fibers as provider of afferent inputs or of aggravating factors that we could also use as potential therapeutic target \[[@B25], [@B33], [@B34]\].

Is pain-related behavior linked to this ectopic firing? Indeed in neuropathic models, onset of activity is strongly related to the generation of pain \[[@B17], [@B31], [@B35], [@B36]\]. Ectopic discharges were even correlated with pain-related behavior at the early phase of nerve injury but not later on \[[@B37]\].

In a translational perspective, a nerve blockade, peripheral or neuraxial, should therefore cover impulse from both myelinated and unmyelinated fibers in the postoperative period. The minimal timeframe until peripheral input is no longer associated with pain-related behavior after surgery still has to be defined. Interestingly, for the clinical setting, Brennan\'s group recently paralleled guarding behavior in rodents to spontaneous pain in postoperative patient. They were able to show that skin plus deep tissue incision induces a guarding behavior and increased spontaneous afferent activity which was not present in skin incision alone \[[@B38]\]. This brings to attention that spontaneous activity can appear in an inflammatory model without obvious nerve injury as seen in our daily surgical activity.

3. Advantages and Limits of Animal Research {#sec3}
===========================================

The necessity of animal models has always been criticized \[[@B39], [@B40]\]. A few well-known failures to translate research findings into clinical trials, NK-1 antagonists \[[@B41]\], glycine site antagonist \[[@B42]\], or sodium channel blockers \[[@B43]\] remind us of the potential gaps between animals and humans. On the other hand, examples of successful translational research exist such as conotoxin, which revealed a new mechanism in pain development and lead to a new treatment \[[@B44]\]. New compounds are coming to clinical trial, nerve growth factor (NGF) inhibitor \[[@B45], [@B46]\], or transient receptor potential vanilloid receptor 1 (TRPV1) antagonists \[[@B47], [@B48]\].

Three current limitations in humans are cited by Mogil \[[@B40]\], (i) single neuron recording which gives valuable information is not obtainable in human, (ii) functional magnetic resonance imaging reaches a ceiling and high activity in neurons cannot be differentiated, and (iii) some regions of interest such as the spinal cord dorsal horn or the DRG are too small to be seen clearly. Therefore, most human studies characterize pain states and do not look at anatomical, biochemical, or physiological mechanisms. We are however able to see an increase in imaging studies which, together with quantitative sensory testing, represent the best mechanistic approach feasible in living patients and with technical improvement some limitations seen above will be overcome.

An obvious advantage of animals is the standardization of the injury and of the genetic and environmental background and avoiding any social factors. Nerve injuries on patients are heterogeneous and, therefore, difficult to study. We will here highlight the advantages and the limits of animal research specifically looking at nerve blockade issues.

3.1. Advantages of Animal Research {#sec3.1}
----------------------------------

\(a\) Sustained BlockThe influence of duration and initiation of epidural nerve blockade to prevent chronic changes after amputation has been studied clinically already 20 years ago with controversial results \[[@B10], [@B49]\]. For local anesthetics, delivery through slow release polymer is complicated and therefore peripheral or central nerve blockade lasting more than a few hours in patients implies the placement of a catheter. The length of a clinical block will depend on practical issues such as surveillance, costs, risks of catheter infection \[[@B50]\] or ambulatory surgery. In experimental research, slow release devices in development can already be used to block nerves over a few days \[[@B35]\]. By combining a slow release system (microspheres loaded with bupivacaine and a small amount of dexamethasone) with an entrapment (embedding the spheres in fibrin glue inside a silicon tube), we could achieve a complete sciatic nerve block for a week with complete recovery thereafter \[[@B51]\].

\(b\) Selective BlockAs mentioned above, discharges originate in different fiber types depending on the injury model and timing. In clinical setting pain (nociceptive), specific blockade is achieved by reducing the concentration of the local anesthetics. Lots of research is ongoing to discover blockers whose targets are specifically expressed on nociceptors such as TRPV1 or specific isoforms of sodium channels.TRPV1 can be blocked by an agonist as capsaicin or resiniferatoxin (RTX) which induces a desensitization of the nerve fiber for a longer period. In our hands, RTX directly applied on the sciatic nerve induced a selective block to heat stimulation for 3 days without affecting the response to mechanical stimulation or impairing motor ability. From the 9 voltage-gated sodium channels currently described (Nav1.1--1.9), Nav1.7, 1.8, and 1.9 are almost selectively expressed on nociceptors. No specific blocker of these channels has yet completed clinical trials successfully but compounds are still being tested \[[@B52]\]. These methods of selectively blocking nociceptors are not used in the perioperative setting, yet but in research they are useful tools to study the influence of selective fibers on the mechanisms of pain.

\(c\) Evaluation during the BlockadeMotor/sensitive block and pain levels can be assessed during peripheral or central nerve blockade whereas long-term outcomes as chronic pain or functional recovery can be checked later. We know many plastic changes occur in the perioperative period. In animals, tissue can be harvested during the blockade to study which mechanism are changed.

\(d\) Electrophysiological RecordingsThe most important effect of peripheral or central nerve blockade is impeding discharge to pass from periphery to the brain, thereby inhibiting pain. Fundamental research on pathophysiological mechanisms (ectopic electrical activity-dependant or -independent changes, location, and timing of nerve activity) can give hints to clinicians where to block, when, and for how long. Then, clinical trials based on these mechanisms could be designed. Besides observational studies on discharge characteristics in different models, electrophysiological recordings allow to study the effect of blockade on subsequent discharge patterns.

3.2. Limits in Animal Research {#sec3.2}
------------------------------

Behavioral studies in animals are not an easy task. Subject to interobserver and interindividual variability, they integrate many different aspects of the pain pathways (spinal withdrawal reflexes, spino-bulbospinal reflexes as jumping, simple innate behaviors as guarding or licking, or more complicated learned behaviors) depending on the test used. The limits often put forward in animal models are the following: assessment of evoked-pain behavior and not spontaneous pain, no vocalization in the audible range, or no characterization of symptoms. We have to be aware of the limitations when we transfer our results to a clinical application and stay humble when we want to claim the mechanisms in animals and humans are comparable. We hope for mechanistic research in human to improve and to guide our laboratory hypotheses.

4. Clues from the Bench {#sec4}
=======================

Detailed effects of blocks on nerve injury models are summarized in [Table 1](#tab1){ref-type="table"} and the description of the models in [Figure 1](#fig1){ref-type="fig"}. We will highlight the general ideas below.

4.1. Effects of Timing and Duration of Block on Behavior {#sec4.1}
--------------------------------------------------------

\(i\) Effect of TimingThe question of whether a nerve blockade has to be effective before or only after surgery is still unresolved. Few experimental studies compared the exact same treatment given before and after lesion. Fletcher et al. demonstrated a better effect on hyperalgesia when injecting bupivacaine in the paw before than after carrageenan \[[@B53]\]. The difference was even sustained when a second dose of carrageenan was injected a week later \[[@B54]\]. This underlines that priming of the nociceptive or sensitive system can be induced by a first injury without being noticed until it is unraveled by the magnified response to a second insult. In a model of intravesical acrolein injection, the timing of lidocaine injection influenced the referred mechanical hyperalgesia on the hindpaws but not the biochemical changes in the bladder itself \[[@B55]\], which points to activity dependant phenomenon or not. Pain mechanisms also change during development: a nerve blockade was done before or after a paw incision in 2-week or 4-week-old rat pups, the preinjury block was only more effective in the 2 weeks old pups \[[@B56]\]. Short block before injury reduced long-term pain-related behavior in the CCI model \[[@B57]--[@B59]\], but not in the partial sciatic nerve ligation (PSNL) \[[@B57]\], SNL \[[@B60]\], or spinal nerve cryoneurolysis models \[[@B61]\]. Sometimes the block only delayed heat hyperalgesia in the CCI \[[@B62]\] or mechanical allodynia in the SNL \[[@B63]\]. In the pain clinic, as opposed to the perioperative setting, preventive block cannot be done and we want to know if nerve blockade is useful once pain is established. This is a fundamental pathophysiological issue to know if peripheral inputs still contribute to maintenance of pain or if pain has become a self-maintained central process. Local anesthetic on the dorsal root or spinal nerve after establishment of neuropathic pain could alleviate transiently mechanical and cold allodynia after SNL \[[@B34], [@B60]\] and inhibiting distal afferent in the CCI model was effective on heat hyperalgesia \[[@B64]\].The clinical implication of these results is that it is probably useful to perform a nerve blockade before the surgery rather than only starting after. Even if the pain is already established it is worth to use peripheral nerve blockade to test if peripheral nerve activity still participates to the pain process.

\(ii\) Effect of DurationApart from the question of when to commence the block, the duration of any perioperative nerve blockade is often questioned. To answer, studies compare the same treatment for short versus long period. In animal inflammatory pain models, repeated injections or bupivacaine-microspheres but not a single injection of bupivacaine reduced pain behavior \[[@B65]--[@B67]\]. In the paw incision model, which simulates inflammatory postoperative pain, longer block is more effective for relieving primary and secondary hyperalgesia \[[@B68]\]. For neuropathic pain, a one-week-long peripheral nerve blockade in the SNI model did not prevent pain-related behavior \[[@B51]\], whereas slow release bupivacaine placed at the time of lesion could prevent it in the same model and in the CCI \[[@B35]\].

Clinically, the suspicion that a longer block of nociceptive input could possibly prevent the development of chronic pain states has newly been discussed in the context of phantom limb pain after amputation. While older studies never managed to demonstrate a beneficial effect of epidural or peripheral nerve blocks, a recent observational study revealed astonishingly few patients suffering from phantom limb pain one year after lower limb amputation with prolonged peripheral nerve block performed as peri- and postoperative pain treatment (median duration of block 30 days) \[[@B69]\]. There are clinical and experimental arguments in favor of a long-term block but the duration with the best ratio of risk/benefit has yet to be found.

4.2. Biochemical Changes Affected by Blockade {#sec4.2}
---------------------------------------------

During the period of a regional blockade, behavioral analysis is difficult due to the sensory impairment. Animal research allows observation of changes occurring along the pain pathways during that period by means of tissue collection and analysis. Early signs of neuronal activation in the spinal cord assessed by increased labeling of c-fos (a transcription factor that leads to expression of proteins) is reduced by nerve blockade in inflammatory \[[@B70]\] and postoperative \[[@B71]\] models of pain. Cyclo-oxygenase 2 (COX2) induction and production of prostaglandin E2 (PGE2) in the CNS is also dependent on peripheral nerve inputs \[[@B72], [@B73]\]. In the SNI model, we found a sciatic nerve blockade which reduces the apoptotic cell death in the spinal cord dorsal horn. This cell death affects inhibitory interneurons. It participates in the disinhibition process involved in the hyperexcitability of the system leading to pain-related behavior. Sadly, the cell death reduction is not long-lasting but only postponed until the end of the block \[[@B74]\]. Microglia and astrocytes, 2 types of glial cells (nonneuronal cell population of the CNS) have been implicated in pain processing \[[@B75], [@B76]\]. They are generally said to be activated in the context of pain. This activation was reduced in neuropathic pain model through peripheral nerve blockade \[[@B77], [@B78]\].

The idea of a magic bullet curing all pain has vanished. Therefore, categorizing specific aspects of sensitization processes into activity-dependent or -independent phenomena is useful to know when to use a blockade. These results also favor the concept of multimodal analgesia combining peripheral or central nerve blockade to systemic drugs on various targets.

4.3. Effects of Specific Block {#sec4.3}
------------------------------

In clinical postoperative setting, we adjust the concentration of local anesthetic to obtain a selective nociceptive blockade, which does not block nerve activity arising in thicker myelinated fibers. The paralysis of the limb induced by A-*β* fibers blockade cannot be accepted for a long period due to risk of sore lesions, loss of muscle mass hindering rehabilitation, and masking of complications. Indeed, complications of nerve blockade (nerve injury, hematoma, infection) are suspected when a motor deficit appears or persists \[[@B79]\].

In the SNI model, we compared the effect of complete block (using bupivacaine) to specific nociceptive block with RTX (TRPV1 agonist, inducing desensitization of the receptor). Microglial activation was reduced only by the complete block \[[@B80]\]. Tetrodotoxin (TTX) is a sodium channel blocker. Nociceptive fibers contain TTX-resistant sodium channels, and, therefore, myelinated fibers are preferentially blocked by TTX. TTX could prevent neuropathic pain-related behavior after CCI, SNL, and stimulation-induced pain \[[@B35], [@B81]\], but failed to reduced flinching in an inflammatory model compared to lidocaine \[[@B82]\]. These examples from animal blockade of specific nerve type highlight the paramount importance of thick myelinated fibers in sensitization processes especially in neuropathic pain. Indeed, we mentioned ectopic activity in myelinated axons after injury coincides with tactile allodynia \[[@B37]\].

We believe partial blockade such as currently performed, especially with an epidural, could be a reason of failure to prevent chronic postoperative pain despite using pre-emptive long-term block. Older clinical studies already pointed the differential effect of epidural versus spinal intensity of blockade. When both techniques are used at levels were cold and pinprick sensation is abolished, temporal summation is conserved in the epidural group, showing sensitization process might occur in the background of a painless patient \[[@B83], [@B84]\].

4.4. Other Effects of Nerve Block {#sec4.4}
---------------------------------

Local anesthetics have many systemic or local properties besides impeding nerve conduction through voltage-gated sodium channels inhibition.

\(i\) The Anti-Inflammatory Effects of Nerve BlockadeThe systemic inflammation tested by the levels of cytokines in the blood is reduced by bupivacaine, and this effect is systemic as ipsi, contralateral block and even contralateral intramuscular injection is effective \[[@B85]\]. In a human model of secondary hyperalgesia, local anesthetic had a systemic effect \[[@B86]\] which is clinically relevant as area of hyperalgesia in the acute postoperative period correlates with the incidence of postoperative chronic pain \[[@B87]--[@B89]\].

\(ii\) Axonal TransportBesides electric discharges axonal transport is another way of signaling a peripheral nerve injury to the CNS. Experimental axonal transport block could influence behavioral and glial changes after nerve injury \[[@B90]\]. Recently bupivacaine has been shown in vivo to inhibit the retrograde transport of TNF*α* after an inflammatory insult \[[@B91]\].

These less known pharmacologic properties of local anesthetics may contribute to the often observed "therapeutic effect" of local anesthetics injection in interventional pain management of certain chronic pain patients, such as facet joint nerve blocks (a) or epidural infiltrations (b), were local anesthetic administration alone often show the same favorable results as their coadministration with corticosteroids. It is also in this context, that previously performed randomized "placebo" controlled trials with negative results comparing the beneficial effect of the combined administration of corticosteroids and local anesthetics with patients receiving local anesthetics alone, as for example for cervical periradicular injections (c), lacked a real placebo group.

5. Conclusions and Back to Bedside {#sec5}
==================================

In clinical practice, nerve blocks are effective for treatment of acute postoperative pain but their impact on the prevention of chronic postoperative pain shows conflicting results. This paper intended to highlight some of the factors found in experimental studies. The main reason is the blockade limited to nociceptors with absence of blockade of myelinated thicker afferents. The latter account for most of the afferent activity after injury and experimental evidence show they participate in pain related behavior. Perioperative block limited to nociceptive fibers reduces the acute pain and we are maybe missing the sensitization phenomena that occur insidiously at the same time through the myelinated afferents, driving the chronification of the pain process. We mentioned the recent study with long-term block of all fibers \[[@B69]\], although only observational, giving encouraging results on chronic outcomes. For postoperative epidural analgesia, it will not be possible to fully block the inputs over a few days but for peripheral nerve blockade a more intense block can be considered. We have to define the best duration of both peripheral and epidural blockade balancing the advantages of inhibiting some central processes with the risks inherent to these techniques (infection, local anesthetic toxicity, etc.). With regards to the failure of some regional anesthesia techniques we have to keep in mind that some changes might be activity-independent and must, therefore, be addressed by other means. This involves multimodal analgesia combining complementary treatment associating systemic drugs to the regional technique.

This paper was supported by the Swiss National Science Foundation (Swiss Pain Consortium, SPUM grant, 33CM30-124117), Bern, Switzerland.

![Schematic of the major animal models of nerve injury. Rhizotomy consists of section of dorsal roots; SNL: spinal nerve ligation, usually L5 or L5 and L6; CCI: chronic constriction injury consists of loose ligations of the sciatic nerve; SNI: spared nerve injury, consists of section of the tibial and the peroneal branches leaving the sural intact.](ARP2011-124898.001){#fig1}

###### 

Effect of block on animal nerve injury models. Single means one application, local means on the injury site, and pre-emptive: yes: before the injury. SNL: spinal nerve ligation, CCI: chronic constriction injury, SNI: spared nerve injury, Seltzer: partial sciatic nerve ligation, d: day(s), dpi: day(s) postinjury, iv: intravenous, it: intrathecal, ip: intraperitoneal, ttt: treatment, DRG: dorsal root ganglion, SC: spinal cord, RTX: resiniferatoxin, and TTX: tetrodotoxin.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author                                          Year     Drug                  Duration          Route                                                          Preemptive     Model                                        Time of effect                  Effect
  ----------------------------------------------- -------- --------------------- ----------------- -------------------------------------------------------------- -------------- -------------------------------------------- ------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Behavioral changes*                                                                                                                                                                                                                                        

                                                                                                                                                                                                                                                              

  I. Kissin                                       1999     N-b-tetracaine        single            saphenous                                                      yes            saphenous transection                        7 dpi                           Prevention early pressure hyperalgesia, caused hyperalgesia alone at 10 d

  Lidocaine                                       Single   saphenous             yes               saphenous transection                                          1 dpi          Prevention early pressure hyperalgesia                                       

                                                                                                                                                                                                                                                              

  Y. W. Yoon                                      1996     Bupivacaine           Single            dorsal root L4/5 5 dpi                                         no             SNL L5/6                                     5 dpi                           L5: reduction of mechanical + cold allodynia and ongoing pain; L4: reduction of mechanical + cold allodynia

                                                                                                                                                                                                                                                              

  Z. Seltzer                                      1991     Marcaine              Single            sciatic/\                                                      yes            sciatic/\                                                                    Autotomy is delayed and its magnitude decreased
                                                                                                   saphenous                                                                     saphenous\                                                                   
                                                                                                                                                                                 transection                                                                  

                                                                                                                                                                                                                                                              

  P. M. Dougherty                                 1991     Lidocaine             Single            sciatic                                                        yes            CCI                                          3 and 10 dpi                    Reduction in duration and magnitude of thermal hyperalgesia

  Lidocaine                                       Single   sciatic               yes               Seltzer                                                        3 and 10 dpi   No effect                                                                    

                                                                                                                                                                                                                                                              

  S. Abdi                                         2000     Lido/bupivacaine      Single            local before or 4 dpi                                          yes/no         SNL L5/L6                                    1 d after ttt                   Reduction of mechanical allodynia, no long-term effect

                                                                                                                                                                                                                                                              

  J. M. Zhang                                     2000     Lidocaine             During 1 or 8 d   DRG following injury                                           no             DRG compression                              1--28 dpi                       Reduction of mechanical allodynia and hyperalgesia ipsilaterally with partial effect contralaterally

                                                                                                                                                                                                                                                              

  L. Luo                                          1995     Lido/tocainide        Single            it                                                             yes            sciatic section                              42 d after ttt                  No effect on autotomy

                                                                                                                                                                                                                                                              

  S. R. Chaplan                                   1995     Lidocaine             Single            iv, it, local, 28 dpi                                          no             L5/L6 ligation                               21 d after ttt                  Reduction of mechanical allodynia only if plasma concentration was high enough, no long-term effect of local and it

                                                                                                                                                                                                                                                              

  J. Mao                                          1992     Bupivacaine           Single            sciatic, 3 dpi                                                 no             CCI                                          1 d after ttt                   Reduction of thermal hyperalgesia

                                                                                                                                                                                                                                                              

  J. M. Gonzalez-Darder                           1985     Mepivacaine           Single            local                                                          yes            sciatic section                              7--70 dpi                       Reduction and delay of autotomy

                                                                                                                                                                                                                                                              

  M. L. Sotgiu                                    1995     Lidocaine             Single            sciatic, iv or iv                                              yes            CCI                                          21 dpi                          Reduction in paw licking during 2-3 weeks, then no difference

                                                                                                                                                                                                                                                              

  I. Bileviciute-Ljungar                          1999     Lidocaine             Repeat            sciatic contra, 6 + 11 dpi                                     no             CCI                                          36 dpi                          Reduction of thermal hyperalgesia 3-4 d, small effect on pressure stimulation, reduction of autotomy 36 d

                                                                                                                                                                                                                                                              

  T. Yamamoto                                     1993     Bupivacaine           Single            sciatic                                                        yes            CCI                                          till 14 dpi                     Delaying of thermal hyperalgesia until day 14

  Bupivacaine                                     Single   sciatic 15 min post   no                CCI                                                            7 dpi          No effect on thermal hyperalgesia                                            

                                                                                                                                                                                                                                                              

  M. R. Suter                                     2003     Bupvacaine            Long term         sciatic/spheres                                                yes            SNI                                          4 weeks                         No effect on mechanical allodynia, thermal hyperalgesia, cold allodynia

                                                                                                                                                                                                                                                              

  Y. S. Lyu                                       2000     TTX                   Single            DRG                                                            no             Chung L5 ligation                            2 h after ttt                   Reduction of mechanical allodynia, no long-term effect

                                                                                                                                                                                                                                                              

  S. R. Chaplan                                   2003     ZD7288                Single            ip, 7 dpi                                                      no             SNL L5/6                                     1 day after ttt                 Reduction in mechanical allodynia for 2 h, no effect at 24 h

                                                                                                                                                                                                                                                              

  L. M. Batista                                   2009     Lidocaine             Single            sciatic                                                        yes            CCI, nylon                                   over 28 days                    Reduction of scratching, thermal hyperalgesia (noxious and non-noxious)

                                                                                                                                                                                                                                                              

  I. Sukhotinsky                                  2004     Lidocaine             Single            DRG L4 or L5                                                   no             SNL                                          280 min                         Reduction allodynia from 2 to 280 min after ttt, more effective on L5 than on intact L4

                                                                                                                                                                                                                                                              

  S. Eschenfelder                                 2000     Lidocaine             Single            dorsal root L5 before section                                  yes            SNL L5                                       57 dpi                          No difference for mechanical hyperalgesia

                                                                                                                                                                                                                                                              

  *Biochemical or electrophysiological changes*                                                                                                                                                                                                               

                                                                                                                                                                                                                                                              

  J. M. Zhang                                     2004     Lidocaine             7 d               ip, pump                                                       no             SNL                                          7 and 14 dpi                    Reduction in tyrosine hydroxylase staining

  Lidocaine                                       14 d     sciatic, pump         yes               sciatic transection                                            14 dpi         Reduction in tyrosine hydroxylase staining                                   

                                                                                                                                                                                                                                                              

  C. T. Lin                                       2009     Lidocaine             Single            median nerve                                                   yes            median nerve transection                     28 dpi                          Dose dependent reduction of injury discharge pre and post electrical stimulation and of NPY and c-fos in cuneate nucleus

                                                                                                                                                                                                                                                              

  I. Omana-Zapata                                 1997     TTX                   Single            intravenoous                                                   no             sciatic transection                          4--10 days                      Dose dependent reduction of ectopic activity

                                                                                                                                                                                                                                                              

  I. Bileviciute-Ljungar                          2001     Lidocaine             Single            contralateral subcutaneous                                     no             CCI                                          14 dpi                          WDR L4/5 neuron ipsilateral: spontaneous hyperactivity reduced for 60 min

                                                                                                                                                                                                                                                              

  L. A. Colvin                                    2001     Amethocain            Single            dorsal roots L2--6                                             no             CCI                                          10--14 dpi                      No effect on neuropeptide Y release in spinal cord (measurement period of 2 h)

                                                                                                                                                                                                                                                              

  J. Scholz                                       2005     Bupivacaine           7 d               sciatic, spheres                                               yes            SNI                                          7 dpi                           Delay in apoptosis of inhibitory interneurons in the dorsal horn of spinal cord

                                                                                                                                                                                                                                                              

  Y. R. Wen                                       2007     Bupvacaine            3 d               sciatic, spheres                                               yes            SNI                                          3 dpi                           Inhibition of p38MAPK activation in microglia in the spinal cord dorsal horn

                                                                                                                                                                                                                                                              

  W. Xie                                          2009     Bupivacaine/TTX       Long term         sciatic/DRG pump 7d                                            no             SNI/SNL                                      1--10 dpi                       TTX: inhibition of NGF increase (DRG, d3) OX-42 (SC, d3) and GFAP (SC, d10); both: inhibition of glial activation (DRG, d1--10)

                                                                                                                                                                                                                                                              

  S. I. Chi                                       1993     Local anesthetic                        sciatic or systemic                                            no             sciatic transection                          2 and 14 dpi                    Reduction in c-fos immunoreactivity in dorsal horn of spinal cord

                                                                                                                                                                                                                                                              

  S. I. Chi                                       1993     Lidocaine                               sciatic or systemic                                            yes            sciatic transection                          2 dpi                           Reduction in c-fos immunoreactivity in dorsal horn of spinal cord

                                                                                                                                                                                                                                                              

  M. R. Suter                                     2009     Bupivacaine/RTX       2 d               sciatic, spheres                                               yes            SNI                                          2 dpi                           Bupi: inhibition of microglia proliferation and p38MAPK activation in dorsal horn of spinal cord; RTX: no effect

                                                                                                                                                                                                                                                              

  *Mixed outcomes*                                                                                                                                                                                                                                            

                                                                                                                                                                                                                                                              

  L. Liang                                        2010     TTX                   Repeat            sciatic, daily                                                 yes            electrical stimulation                       up to 35 dpi                    Reduction of mechanical allodynia, GFAP-staining on DRG

                                                                                                                                                                                                                                                              

  B. A. Rooney                                    2007     Lidocaine             Single            dorsal root                                                    yes            bilateral dorsal root L4/5 section           up to 13 days                   No increase in excitatory amino acid 10 min post injury, reduction in mechanical allodynia

                                                                                                                                                                                                                                                              

  W. Xie                                          2005     Bupivacaine           Long term         sciatic, after lesion                                          no             CCI and SNI                                  up to 70 d (CCI), 150 d (SNI)   Reduction in mechanical and heat pain for 60 d (CCI + SNI), suppression of hyperactivity at 20--28 dpi in A and C fibers

                                                                                                                                                                                                                                                              

  W. Xie                                          2005     TTX                   Long term         sciatic, TTX (pump 3 or 7 d) just after lesion or 10 d later   no             CCI and SNI                                  up to 70 d (CCI), 150 d (SNI)   Reduction in mechanical and heat pain for 60 d (CCI + SNI), TTX 10 d effective only during infusion, suppression of hyperactivity at 20--28 dpi in A and C fibers

                                                                                                                                                                                                                                                              

  R. W. Colburn                                   1997     Bupivacaine           Repeat            spinal nerve before cut + before closure                       yes            spinal nerve cryoneurolysis                  10 dpi                          Reduction of microglial, but only minimal on astrocytic response, no effect on mechanical allodynia

                                                                                                                                                                                                                                                              

  S. Lee                                          2007     Lidocaine             Single            spinal nerve, it                                               yes            SNL L5/6                                     1--4 dpi                        Delay in mechanical allodynia by 1--4 d

                                                                                                                                                                                                                                                              

  C. Sato                                         2008     Ropivacaine           Repeat            epidural, daily 7--17 dpi                                      no             CCI                                          since 11 dpi                    Relief of thermal hyperalgesia, small reduction of mechanical allodynia, NGF increase in DRG with ropivacaine

                                                                                                                                                                                                                                                              

  W. Xie                                          2007     TTX                   7 d               sciatic, pump                                                  yes            sciatic transection                          35--49 dpi                      Reduction of hyperexcitability of large and medium cells and sympathetic sprouting. No change in C fiber through TTX
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

[^1]: Academic Editor: Gabriella Iohom
